News Sentiment

BTMD sentiment intelligence

biote Corp news scored across direct company coverage, industry context, sector read-through, source quality, and freshness.

Chart Weekly report Factors RSS feed
Weighted score 48 Balanced news tone 55 relevant articles
Exchange NASDAQ United States
Sector Healthcare Market context
Industry Medical Care Facilities Read-through group
Latest close 2.33 Week of 10 Jul 2026
Weighted tone 48/100

Balanced news tone

Market reaction Price moving ahead of tone

Price is moving more forcefully than the current news tone suggests.

Primary event Market update

78/100 classification confidence.

Company focus 55

directly relevant articles

Source quality 1

high-authority source matches

Trend context Trend inactive

+7.4% over one week, -5.3% over four weeks, trend inactive, and below fair value.

Latest direct headline Neutral

Tranche Update on biote Corp.'s Equity Buyback Plan announced on January 25, 2024.

Market Reaction

Price moving ahead of tone

60/100 confidence

Price is moving more forcefully than the current news tone suggests.

Primary event Market update 78/100 classification
One-week reaction 7.4% Price confirming higher
Trend fit Trend inactive -5.3% over four weeks
Fair value -47.0% Below fair value
Value support

Sentiment Mix

Positive, neutral, negative

Weighted by relevance
Positive 5
Neutral 39
Negative 11

Relevance

Why the article matched

Direct first
Direct company coverage 55
Industry context 0
Sector context 0

Sources

Coverage mix

Publishers
Stock Titan 18
TradingView 4
marketscreener.com 3
dars.gov.et 3
Market source 3
Simply Wall Street 2
Quiver Quantitative 2
Investing.com 2

Event Lens

What the news is about

Classified themes
Market update 28
Earnings 12
Regulatory and legal 6
Guidance 4
Deals and strategy 2
Balance sheet 2
Capital return 1

Sentiment Trail

Score over time

50 baseline
Above 50 Neutral zone Below 50

News Tape

Relevant headlines

Showing 31-55 of 55
Quiver Quantitative Direct company coverage

Biote Corp. (BTMD) Releases Q1 2026 Earnings: Revenue Falls 8.3% While EPS Beats Estimates

Biote Corp. (BTMD) reported its Q1 2026 earnings, showing an 8.3% year-over-year decrease in revenue to $44.9 million and a 14.9% decline in gross profit to $31.0 million. Despite the revenue shortfall compared to estimates, diluted EPS of $0.06 surpassed the $0.05 expectation. T

Tone
Negative 39/100
Event
Earnings
Published
06 May 2026 22:40
Source
Quiver Quantitative
Stock Titan Direct company coverage

biote (BTMD) grants 88,800 stock options to General Counsel Monico

biote Corp. (BTMD) has granted its General Counsel, Daniel Michael Monico, 88,800 employee stock options for Class A common stock at an exercise price of $2.19 per share. These options are part of Monico's compensation package and will vest in two stages: half on April 27, 2028,

Tone
Neutral 50/100
Event
Market update
Published
04 May 2026 20:28
Source
Stock Titan
lawfold.com Direct company coverage

Biote Lawsuit 2026: Claims, Risks & How to File

Biote Medical faces legal action in 2026 over its hormone pellet therapy, with patients alleging harm and misleading marketing regarding its safety and risks. The lawsuits, which include claims of negligence, product liability, and consumer fraud, center on complications like car

Tone
Negative 15/100
Event
Regulatory and legal
Published
13 Apr 2026 09:40
Source
lawfold.com
Stock Titan Direct company coverage

Biote (NASDAQ: BTMD) highlights 2025 revenue and 2026 guidance

Biote (NASDAQ: BTMD) has released an updated investor presentation detailing its 2025 performance and 2026 outlook. For 2025, the company reported revenues of $192.2 million and Adjusted EBITDA of $53.5 million. Looking ahead to 2026, Biote expects revenue to exceed $190 million

Tone
Positive 76/100
Event
Guidance
Published
03 Apr 2026 21:39
Source
Stock Titan
TradingView Direct company coverage

Biote posts April 2026 investor presentation highlighting $192.2M 2025 revenue and $53.5M Adj. EBITDA

Biote has released its April 2026 investor presentation, detailing its 2025 financial performance with $192.2 million in revenue and $53.5 million in adjusted EBITDA. The company also reported having over 9,200 certified practitioners and nearly 400,000 active patients by the end

Tone
Positive 73/100
Event
Earnings
Published
03 Apr 2026 20:41
Source
TradingView
Stock Titan Direct company coverage

biote Corp. (BTMD) CFO receives 107,169 employee stock options at $1.43

biote Corp.'s Chief Financial Officer, Robert Charles Peterson, was granted 107,169 employee stock options for Class A Common Stock with an exercise price of $1.43 per share. These options expire on March 31, 2036, and vest over time, with 25% vesting on April 1, 2027, and the re

Tone
Neutral 50/100
Event
Market update
Published
03 Apr 2026 17:39
Source
Stock Titan
Stock Titan Direct company coverage

biote Corp. (BTMD) CEO awarded 441,653 stock options at $1.43 strike price

biote Corp.'s CEO, Bret Christensen, has been granted 441,653 employee stock options with a strike price of $1.43 per share. These options are part of his compensation, with 25% vesting on April 1, 2027, and the remainder vesting in 36 monthly installments thereafter, contingent

Tone
Neutral 50/100
Event
Market update
Published
03 Apr 2026 17:39
Source
Stock Titan
Stock Titan Direct company coverage

Biote (BTMD) details 2026 virtual meeting, board elections and pay

Biote Corp. (BTMD) has announced its 2026 annual virtual stockholder meeting for May 12, 2026, where shareholders will vote on electing two Class I directors and ratifying Deloitte & Touche LLP as its independent auditor. The proxy statement also provided details on board composi

Tone
Neutral 50/100
Event
Market update
Published
02 Apr 2026 20:19
Source
Stock Titan
Simply Wall Street Direct company coverage

biote (BTMD) Balance Sheet & Financial Health Metrics

This article provides an overview of biote (BTMD)'s financial health and balance sheet metrics. It highlights key figures such as a negative shareholder equity of $-50.4M and total debt of $107.0M, resulting in a debt-to-equity ratio of -212.4%. The company's EBIT is $35.1M, with

Tone
Negative 36/100
Event
Balance sheet
Published
27 Mar 2026 18:09
Source
Simply Wall Street
Markets Mojo Direct company coverage

biote Corp. Stock Plummets to New 52-Week Low of $1.68

biote Corp., a microcap hospital industry company, has reached a new 52-week low of $1.68, experiencing a 73.6% stock price decline over the past year. The company is facing significant financial difficulties, including a negative book value, poor debt management, and decreased n

Tone
Negative 13/100
Event
Balance sheet
Published
21 Mar 2026 06:38
Source
Markets Mojo
Intellectia AI Direct company coverage

Biote Corp. Q4 2025 Earnings Call Insights

Biote Corp. reported a significant expansion of its sales team to over 90 members by the end of 2025 and highlighted a Q4 2025 revenue of $46.4 million, with dietary supplement revenue growing 16% to $11.7 million despite a 13% decline in procedure revenue. The company forecasts

Tone
Positive 63/100
Event
Earnings
Published
14 Mar 2026 20:51
Source
Intellectia AI
Investing.com Direct company coverage

Earnings call transcript: Biote Corp misses Q4 2025 earnings expectations

Biote Corp reported missing its Q4 2025 earnings and revenue forecasts, with an EPS of $0.06 against an expected $0.09 and revenue of $46.4 million versus $47.12 million. Despite the misses and a year-over-year revenue decline of 6.9%, the company's stock remained stable in after

Tone
Negative 35/100
Event
Earnings
Published
14 Mar 2026 18:39
Source
Investing.com
TipRanks Direct company coverage

Biote Corp. Earnings Call Maps Pain Now, Promise Later

Biote Corp.'s Q4 earnings call revealed a mixed performance, with operational gains in dietary supplements and cost controls offsetting declines in its core procedure business due to clinic attrition and a product recall. Despite a drop in revenue and adjusted EBITDA in Q4 2025,

Tone
Neutral 50/100
Event
Regulatory and legal
Published
13 Mar 2026 13:39
Source
TipRanks
TradingView Direct company coverage

biote Corp. SEC 10-K Report

Tone
Neutral 50/100
Event
Market update
Published
14 Mar 2025 07:00
Source
TradingView